Temporal Associations of the SARS-CoV-2 NP Antigen and Anti-Spike Total Ig Levels with Laboratory Parameters in a Greek Cohort of Hospitalized COVID-19 Patients
Data
2021Language
en
Soggetto
Abstract
Background. The direct effect of SARS-CoV-2 on the lungs results in increased hospitalization rates of patients with pneumonia. Severe COVID-19 patients often develop ARDS which is associated with poor prognosis. Assessing risk factors for COVID-19 severity is indispensable for implementing and evaluating therapeutic interventions. We investigated the temporal associations between the SARS-CoV-2 antigen (Ag), total Immunoglobulin (Ig) levels, and several laboratory parameters in hospitalized patients with varying degrees of COVID-19 severity. Methods. The SARS-CoV-2 nucleocapsid protein (NP) and total Ig Spike (S) protein-specific antibodies were determined for each patient with lateral flow assays through repeated sampling every two days. Hematological and biochemical parameters were evaluated at the same time points. Results. 40 Greek COVID-19 patients (31 males, 9 females) with a median age of 59.50 ± 16.21 years were enrolled in the study. The median time from symptom onset to hospitalization was 8.0 ± 4.19 days. A significant negative correlation was observed between the SARS-CoV-2 Ag and total Ig levels. The temporal correlation patterns of the SARS-CoV-2 NP Ag and anti-S total Ig levels with laboratory markers varied among patients with differing degrees of COVID-19 severity. Severe-critical cases had lower SARS-CoV-2 Ag and increased total Ig levels as compared to mild-moderate cases. Conclusions. Distinct temporal profiles of the SARS-CoV-2 NP Ag and anti-S total Ig levels may distinguish different groups of COVID-19 severity. © 2021 Erasmia Rouka et al.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
Bogogiannidou Z., Vontas A., Dadouli K., Kyritsi M.A., Soteriades S., Nikoulis D.J., Mouchtouri V.Α., Koureas M., Kazakos E.I., Spanos E.G., Gioula G., Ntzani E.E., Eleftheriou A.A., Vatopoulos A., Petinaki E., Papaevangelou V., Speletas M., Tsiodras S., Hadjichristodoulou C. (2020)[No abstract available] -
Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?
Pavlidis G., Kampolis C.F., Perlepe G., Pagonis A., Maniotis C., Koullias E., Kranidioti H., Kyritsis A., Pavlou E., Sinis S., Pirounaki M., Vassilopoulos D., Gourgoulianis K., Pantazopoulos I. (2022)Background/Aim: The relationship between the kinetics of antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of Coronavirus Disease 2019 (COVID-19) is poorly understood. The ... -
Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management
Speletas M., Kyritsi M.A., Vontas A., Theodoridou A., Chrysanthidis T., Hatzianastasiou S., Petinaki E., Hadjichristodoulou C., the COGESE study group (2020)The estimation of anti-SARS-CoV-2 IgG antibodies is possibly the best approach to accurately establish the number of infected individuals and the seroprevalence of COVID-19 within a population. Thus, several commercial ...